You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 22, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
R Eggers1, A Philippi1, M O Altmeyer1
1Environmental safety group, Korea Institute of Science and Technology (KIST Europe), Saarbrücken, Germany.
Human T cells can deliver cancer-fighting immunotoxins via messenger RNA (mRNA) transfection. This approach shows potential for targeted cancer therapy with reduced side effects.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: